These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis. Hollmann CA; Kittrell FS; Medina D; Butel JS Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642 [TBL] [Abstract][Full Text] [Related]
4. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression. Jho Eh; Lomvardas S; Costantini F Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160 [TBL] [Abstract][Full Text] [Related]
5. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853 [TBL] [Abstract][Full Text] [Related]
6. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation. Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683 [TBL] [Abstract][Full Text] [Related]
7. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Esufali S; Bapat B Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999 [TBL] [Abstract][Full Text] [Related]
8. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734 [TBL] [Abstract][Full Text] [Related]
9. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin. Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974 [TBL] [Abstract][Full Text] [Related]
10. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex. Hämmerlein A; Weiske J; Huber O Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065 [TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745 [TBL] [Abstract][Full Text] [Related]
12. Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation. Spychala J; Kitajewski J Exp Cell Res; 2004 Jun; 296(2):99-108. PubMed ID: 15149841 [TBL] [Abstract][Full Text] [Related]
13. Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. Staal FJ; Meeldijk J; Moerer P; Jay P; van de Weerdt BC; Vainio S; Nolan GP; Clevers H Eur J Immunol; 2001 Jan; 31(1):285-93. PubMed ID: 11265645 [TBL] [Abstract][Full Text] [Related]
14. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377 [TBL] [Abstract][Full Text] [Related]